<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Effects of administration of iron, iodine and simultaneous iron-plus-iodine on the thyroid hormone profile in iron-deficient adolescent Iranian girls</dc:title>
  <dc:creator>Eftekhari, M.H.</dc:creator>
  <dc:creator>/Simondon, Kirsten</dc:creator>
  <dc:creator>Jalali, M.</dc:creator>
  <dc:creator>Keshavarz, S.A.</dc:creator>
  <dc:creator>/Elguero, Eric</dc:creator>
  <dc:creator>Eshraghian, M.R.</dc:creator>
  <dc:creator>Saadat, N.</dc:creator>
  <dc:subject>FER</dc:subject>
  <dc:subject>ANEMIE</dc:subject>
  <dc:subject>DEFICIENCE</dc:subject>
  <dc:subject>SUPPLEMENTATION</dc:subject>
  <dc:subject>HORMONE</dc:subject>
  <dc:subject>ADOLESCENT</dc:subject>
  <dc:subject>CONSOMMATION ALIMENTAIRE</dc:subject>
  <dc:subject>ANALYSE STATISTIQUE</dc:subject>
  <dc:subject>ETUDE COMPARATIVE</dc:subject>
  <dc:subject>IODE</dc:subject>
  <dc:subject>FERRITINE</dc:subject>
  <dc:subject>GLANDE THYROIDE</dc:subject>
  <dc:subject>SULFATE DE FER</dc:subject>
  <dc:subject>iron</dc:subject>
  <dc:subject>ferritin</dc:subject>
  <dc:subject>thyroid hormones</dc:subject>
  <dc:subject>supplementation trial</dc:subject>
  <dc:subject>micronutrients</dc:subject>
  <dc:description>Objective: To investigate whether iron supplementation can improve thyroid hormone function in iron-deficient adolescent girls. Design: A double-blind randomized intervention study. Setting: The study was performed from 2002 through 2003 in the Islamic Republic of Iran. Subjects: 103 iron-deficient non-anaemic girls who fulfilled all inclusion criteria were included, and 94 subjects successfully completed the study. Interventions: Patients were randomly assigned to one of four groups and treated with a single oral dose of 190 mg iodine plus 300 mg ferrous sulphate 5 times/week (n = 24), 300 mg ferrous sulphate 5 times/week (n = 23), a single oral dose of 190 mg iodine ( n 25), or a placebo ( n 22) for 12 weeks. Results: All groups were comparable at baseline. After the intervention, there was a significant increase in ferritin and transferrin saturation in the iron + iodine group (17.6 vs 8.7 mu g/dl, and 18.8 vs 7.2%, respectively, P&lt;0.001 for both) and in the iron group (P&lt;0.001 for both). Urinary iodine doubled in the iron + iodine group and in the iodine group ( P&lt;0.001 for both). Thyroid indices tT4, tT3 and T3RU increased and reverse RT3 decreased in the iron + iodine group ( 10 vs 8.9 mu g/dl, P&lt; 0.001; 143 vs 138 mu g/dl, P&lt;0.05; 32.3 vs 28.4%, P&lt;0.001 and 24.8 vs 44.2 ng/dl, P&lt;0.001, respectively) and in the iron group. These two groups did not differ for any of the four indices, but both differed significantly from the iodine and placebo groups. Conclusions: Our results indicate that improvement of iron status was accompanied by an improvement in some indices of thyroid hormones.</dc:description>
  <dc:date>2006</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010035615</dc:identifier>
  <dc:identifier>fdi:010035615</dc:identifier>
  <dc:identifier>Eftekhari M.H., Simondon Kirsten, Jalali M., Keshavarz S.A., Elguero Eric, Eshraghian M.R., Saadat N.. Effects of administration of iron, iodine and simultaneous iron-plus-iodine on the thyroid hormone profile in iron-deficient adolescent Iranian girls. 2006, 60 (4),  545-552</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>IRAN</dc:coverage>
</oai_dc:dc>
